Rx Medicare

A research team from Hong Kong reported a case of repeated laparoscopic hepatectomy treating hepatocellular carcinoma (HCC) and its recurrence in an aged patient having cirrhosis, a disease causing extra difficulty for performing laparoscopic hepatectomy. This case report illustrates that laparoscopic hepatectomy for HCC is a good alternative to open hepatectomy because it has advantages including causing less adhesion after surgery, which renders re-operation much easier in cases of recurrence.

Read More…

Related Posts

• Clinic Closure Leaves Indigent Dialysis Patients Looking For Treatment
• Cardiac Rehab Reduces Death For Elderly Heart Patients
• Doctors, Health Care Workers On H1N1 Vaccine Priority List; Front-Line Caregivers Planning Now To Keep Patients Safe
• 95% Of Patients In Pain Are Still In Moderate To Severe Chronic Pain Despite One Year Of Treatment
• Interventional Radiology Treatment For Uterine Fibroids: Safe, Nonsurgical Option
• Study Of Pulmonary Hypertension Treatment In Sickle Cell Patients Halted By NHLBI
• Study Of Pulmonary Hypertension Treatment In Sickle Cell Patients Stopped Early Due To Safety Concerns
• New Treatment Method Reduces Pain And Increases Mobility In Patients With Vertebral Compression Fractures
• New Treatment Method Reduces Pain In Patients With Vertebral Compression Fractures
• Effective Pain Treatment For Cancer Patients?
• Doctor Recommended Traumeel(R) Offers Patients A Safe And Natural Alternative To NSAIDs
• Research Analyzes Repeat Surgery For Patients Suffering From Recurrent And Painful Trigeminal Neuralgia
• Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
• Treating Back Pain In Blood Marrow Cancer Patients
• Disparity In Cataract Surgery: Medicare Patients 5.5 Times More Likely To Get Surgery Than VA Patients

Tags: carcinoma, elderly, feasible, hepatocellular, patients, recurrent, safe, treatment

This entry was posted on Saturday, February 6th, 2010 at 4:02 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.